Skip to main content
. 2020 Aug 31;3(3):187–201. doi: 10.1093/pcmedi/pbaa030

Table 2.

Distinct properties among three types of PARP inhibitors.

 Item Type I Type II Type III
Inhibitors EB-47, BAD olaparib, talazoparib rucaparib, niraparib, veliparib
PARP-1 allostery allosteric non-allosteric allosteric
HD conformation destabilization neutral more folded
PARP-1 affinity for DNA large increase small increase decrease
Trapping potency pro-retention pro-retention pro-release